Evidence map›Paper›PMID 31049415›Full record

ArticleBJGP open2019

Understanding implementation and usefulness of electronic clinical decision support (eCDS) for melanoma in English primary care: a qualitative investigation.

Merel M Pannebakker, Katie Mills, Margaret Johnson, Jon D Emery, Fiona M Walter

Open access · goldAbstract read
In one paragraph

Article in BJGP open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 5 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 5 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Why aren't they used? Systematic review of barriers to implementation of clinical decision support systems for early cancer detection in primary care.The British journal of general practice : the journal of the Royal College of General Practitioners · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Merel M PannebakkerResearch Associate, The Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Katie MillsResearch Associate, The Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Margaret JohnsonPatient Representative, c/o The Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Jon D EmeryHerman Professor of Primary Care Cancer Research, Department of General Practice and the Centre for Cancer Research, Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Victorian Comprehensive Cancer Centre, Melbourne, Australia.
Fiona M WalterReader in Primary Care Cancer Research, The Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
University of Cambridge · GBUniversity of Melbourne · AUVictorian Comprehensive Cancer Centre · AU

Funding

Department of Health NIHR-CS-012-030
6 · The paper itself

Abstract

backgroundTimely diagnosis of the serious skin cancer melanoma can improve patient outcomes. Clinical guidelines suggest that GPs use checklists, such as the 7-point checklist (7PCL), to assess pigmented lesions. In 2016, the 7PCL was disseminated by EMIS as an electronic clinical decision support (eCDS) tool.

aimTo understand GP and patient perspectives on the implementation and usefulness of the eCDS. DESIGN &

settingSemi-structured interviews with GPs and patients were undertaken. The interviews took place in four general practices in the south east of England following consultations using the eCDS for suspicious pigmented lesions.

methodData were collected from semi-structured face-to-face interviews with GPs and from telephone interviews with patients. They were recorded and transcribed verbatim. The Consolidated Framework for Implementation Research (CFIR) underpinned the analysis using thematic approaches.

resultsA total of 14 interviews with GPs and 14 interviews with patients were undertaken. Most GPs reported that, as the eCDS was embedded in the medical record, it was useful, easy to use, time-efficient, and could facilitate patient-GP communication. They were less clear that it could meet policy or patient needs to improve early diagnosis, and some felt that it could lead to unnecessary referrals. Few felt that it had been sufficiently implemented at practice level. More felt confident with their own management of moles, and that the eCDS could be most useful for borderline decision-making. No patients were aware that the eCDS had been used during their consultation.

conclusionSuccessful implementation of a new tool, such as eCDS for melanoma, requires GPs to perceive its value and understand how it can best be integrated into clinical practice. Disseminating a tool without such explanations is unlikely to promote its adoption into routine practice.

Indexed as

electronic clinical decision support (eCDS)general practicemelanomapatientsqualitativeskin cancer

Identifiers

PMID31049415
PMCPMC6480861
OpenAlexW2924034238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.